These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 25163000)

  • 1. The essential roles of chemistry in high-throughput screening triage.
    Dahlin JL; Walters MA
    Future Med Chem; 2014 Jul; 6(11):1265-90. PubMed ID: 25163000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to Triage PAINS-Full Research.
    Dahlin JL; Walters MA
    Assay Drug Dev Technol; 2016 Apr; 14(3):168-74. PubMed ID: 26496388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Assay Design on Medicinal Chemistry: Case Studies.
    Born JR; Chenniappan VK; Davis DP; Dahlin JL; Marugan JJ; Patnaik S
    SLAS Discov; 2021 Dec; 26(10):1243-1255. PubMed ID: 34225522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.
    Dahlin JL; Nissink JW; Strasser JM; Francis S; Higgins L; Zhou H; Zhang Z; Walters MA
    J Med Chem; 2015 Mar; 58(5):2091-113. PubMed ID: 25634295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
    Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
    ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of HTS in drug discovery at the University of Michigan.
    Larsen MJ; Larsen SD; Fribley A; Grembecka J; Homan K; Mapp A; Haak A; Nikolovska-Coleska Z; Stuckey JA; Sun D; Sherman DH
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):210-30. PubMed ID: 24409957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industrial medicinal chemistry insights: neuroscience hit generation at Janssen.
    Tresadern G; Rombouts FJR; Oehlrich D; Macdonald G; Trabanco AA
    Drug Discov Today; 2017 Oct; 22(10):1478-1488. PubMed ID: 28669605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using information from historical high-throughput screens to predict active compounds.
    Riniker S; Wang Y; Jenkins JL; Landrum GA
    J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interweaving of Cheminformatics and HTS.
    Kümmel A; Parker CN
    Methods Mol Biol; 2011; 672():435-57. PubMed ID: 20838979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False positives in the early stages of drug discovery.
    Sink R; Gobec S; Pečar S; Zega A
    Curr Med Chem; 2010; 17(34):4231-55. PubMed ID: 20939815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-stoichiometric inhibition in integrated lead finding - a literature review.
    Klumpp M
    Expert Opin Drug Discov; 2016; 11(2):149-62. PubMed ID: 26653534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells.
    Kallal LA; Waszkiewicz A; Jaworski JP; Della Pietra A; Berrodin T; Brady P; Jurewicz AJ; Zeng X; Payne L; Medina JR; Doepner-Buser C; Mangatt B
    SLAS Discov; 2021 Feb; 26(2):216-229. PubMed ID: 33482073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting GAINs (Give Attention to Limitations in Assays) over PAINs Alerts: no PAINS, more GAINs.
    Choo MZY; Chai CLL
    ChemMedChem; 2022 Apr; 17(7):e202100710. PubMed ID: 35146933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Small-Molecule Reactivity Identifies Promiscuous Bioactive Compounds.
    Matlock MK; Hughes TB; Dahlin JL; Swamidass SJ
    J Chem Inf Model; 2018 Aug; 58(8):1483-1500. PubMed ID: 29990427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and implementation of high throughput screening assays.
    Macarrón R; Hertzberg RP
    Mol Biotechnol; 2011 Mar; 47(3):270-85. PubMed ID: 20865348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent hits and where to find them.
    Lucas SCC; Blackwell JH; Hewitt SH; Semple H; Whitehurst BC; Xu H
    SLAS Discov; 2024 Apr; 29(3):100142. PubMed ID: 38278484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of chemical space for collaborative lead generation and drug discovery: the European Lead Factory Perspective.
    Karawajczyk A; Giordanetto F; Benningshof J; Hamza D; Kalliokoski T; Pouwer K; Morgentin R; Nelson A; Müller G; Piechot A; Tzalis D
    Drug Discov Today; 2015 Nov; 20(11):1310-6. PubMed ID: 26429298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal HTS Fingerprint Definitions by Using a Desirability Function and a Genetic Algorithm.
    Cortes Cabrera A; Petrone PM
    J Chem Inf Model; 2018 Mar; 58(3):641-646. PubMed ID: 29425455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.